Staar Surgical Stock Analysis

STAAR Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of STAAR Surgical was at this time reported as 7.07. The company has Price/Earnings (P/E) ratio of 460.83. STAAR Surgical recorded a loss per share of 1.44. The entity had not issued any dividends in recent years. The firm had 1:2 split on the 18th of May 1992. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people. To find out more about STAAR Surgical contact Thomas Frinzi at 626 303 7902 or learn more at https://www.staar.com.

STAAR Surgical Investment Alerts

STAAR Surgical Upcoming and Recent Events

STAAR Largest EPS Surprises

View All Earnings Estimates

STAAR Surgical Environmental, Social, and Governance (ESG) Scores

STAAR Stock Institutional Investors

Note, although STAAR Surgical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

STAAR Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 859.77 M.

STAAR Profitablity

The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.81) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.81.

Management Efficiency

STAAR Surgical has return on total asset (ROA) of (0.059) % which means that it has lost $0.059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1914) %, meaning that it created substantial loss on money invested by shareholders. STAAR Surgical's management efficiency ratios could be used to measure how well STAAR Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.12. At present, STAAR Surgical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 148.7 M, whereas Intangible Assets are forecasted to decline to about 147.9 K.

Technical Drivers

As of the 20th of July, STAAR Surgical owns the downside deviation of 3.54, and Risk Adjusted Performance of 0.0239. In relation to fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STAAR Surgical, as well as the relationship between them.

STAAR Surgical Price Movement Analysis

STAAR Surgical Insider Trading Activities

STAAR Surgical Outstanding Bonds

STAAR Surgical Predictive Daily Indicators

STAAR Surgical Corporate Filings

STAAR Surgical Forecast Models

STAAR Surgical's time-series forecasting models are one of many STAAR Surgical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary STAAR Surgical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how STAAR Surgical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling STAAR shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as STAAR Surgical. By using and applying STAAR Stock analysis, traders can create a robust methodology for identifying STAAR entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. STAAR analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. STAAR analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

STAAR Surgical stock analysis indicators help investors evaluate how STAAR Surgical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading STAAR Surgical shares will generate the highest return on investment. By understating and applying STAAR Surgical stock analysis, traders can identify STAAR Surgical position entry and exit signals to maximize returns.

When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.